Briarcliff Manor, NY, United States of America

Danya Spritzer

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Danya Spritzer: Innovator in Biopharmaceutical Compositions

Introduction

Danya Spritzer is a notable inventor based in Briarcliff Manor, NY (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the area of reducing particle formation in drug products. His innovative work has implications for the safety and efficacy of therapeutic compositions.

Latest Patents

Danya Spritzer holds 1 patent for his invention titled "Methods of reducing particle formation and compositions formed thereby." This patent describes biopharmaceutical compositions and drug products that exhibit reduced amounts of subvisible particle formation. The compositions include a protein and a surfactant or stabilizer, featuring high percentage amounts (e.g., at least 97%) of a long-chain fatty acid ester. Additionally, the patent outlines methods for preparing and storing these compositions and drug products.

Career Highlights

Danya Spritzer is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to advance his research in biopharmaceuticals. His work at Regeneron has positioned him as a key player in the development of innovative drug products that prioritize patient safety.

Collaborations

Danya collaborates with talented professionals in his field, including Mayank Patel and Stacy Wasinger. Their combined expertise contributes to the success of their projects and the advancement of biopharmaceutical research.

Conclusion

Danya Spritzer's contributions to biopharmaceutical compositions demonstrate his commitment to innovation and improving drug safety. His work is essential in the ongoing development of effective therapeutic solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…